A switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibitionRichard M. Klein(Pittsburg State University), Paul J. Higgins(Albany Medical Center Hospital)Molecular CancerJanuary 1, 201110.1186/1476-4598-10-114Cited by 28SaveCiteExport RISWatch citationsRelated PapersIntegration of non-SMAD and SMAD signaling in TGF-β1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells|Thrombosis and Haemostasis|2008|98